Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Lopez Fabio

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/29/2017

3. Issuer Name and Ticker or Trading Symbol

SELLAS Life Sciences Group, Inc. [SLS]

(Last) (First) (Middle)

EQUILIBRIA CAPITAL MANAGEMENT LTD., ONE BERMUDIANA ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

HAMILTON, D0 HM08

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Lopez Fabio EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08	X	X
EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. HAMILTON, D0 HM08		X
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. HAMILTON, D0 HM08		X
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund` C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X
EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X
Equilibria Capital Management Ltd C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X
Castilian Ltd. C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X
Varibobi Financial Holdings Ltd C/O EQUILIABRIA CAPITAL MANAGEMENT LTD. O'HARA HOUSE, ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X
Tafur Daniel C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON, D0 HM08		X

Signatures
Fabio Lopez, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
EQC Private Markets SAC Fund II Ltd EQC Biotech Sely S Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
EQC Private Markets SAC Fund Ltd EQC Biotech Sely I Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
EQC Private Markets SAC Fund Ltd EQC Biotech Sely II Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/15/2017
^** Signature of Reporting Person		Date
EQC Private Markets II SAC Fund Ltd EQC Biotech Sely III Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
Equilibria Capital Management Limited, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
Castilian Ltd., Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
Varibobi Financial Holdings Ltd., Fabio Lopez, Authorized Signatory, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date
Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact		12/29/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.